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Abstract 
The objective of this study was the morphological and structural characterisation of glioblastoma multiforme grown in ovo. 
Glioma cells U87 and U118 were implanted in the chorioallantoic membrane (CAM) of chicken egg. After 10 days of incubation, 
tumours were resected for further analyses. Culturing two types of glioblastoma tumours from U87 and U118 cell lines has 
shown a number of differences in their morphology, histology, and ultrastructure. CAM assay proved to be a useful tool for 
studying glioblastoma growth. The model provides an excellent alternative to current rodent models and could serve as a pre-
clinical screening assay for anticancer molecules. It might increase the speed and efficacy of the development of new drugs for 
the treatment of glioblastoma. 
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Introduction 
Glioblastoma multiforme (GBM) is the most 
common and most aggressive primary malignant brain 
tumour. It originates from glial cells and is 
characterised by infiltrative growth and intensive 
migration (5). GBM tends to spread quickly within the 
brain and nervous system but rarely spreads outside it. 
It usually penetrates deeply into the brain, making the 
tumour’s entire removal very difficult. The main 
features of GBM are cell polymorphism and mitotic 
activity, vascular abnormalities, and remarkable 
necrotic foci (1).  
The development of new anti-glioma strategies 
requires the use of appropriate models to evaluate the 
effect of tumours. In vivo glioblastoma models are 
based on the inoculation of glioma cells into the rodent 
brain or the use of transgenic mice causing spontaneous 
tumours. However, these models are weak because they  
 
 
are characterised by variable growth rates and poor 
penetration, and it is also difficult to obtain 
morphological data (3, 4). The chicken embryo 
chorioallantoic membrane (CAM) model is a well-
established method to keep explanted material alive 
and supply it with oxygen and nourishment (1). This 
model provides a useful tool to study the effects of 
molecules, which interfere with experimental tumours 
derived from cancer cell lines (2). 
Glioblastomas are very heterogenic in their 
biological and morphological features. It was assumed 
that the tumours derived from two different glioma cell 
lines are characterised by different morphology, 
structures, and mitotic activity. The objective of this 
study was to evaluate the morphological and structural 
CAM differences between U87 and U118 cultured 
tumours. 
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Material and Methods  
Glioma cells. Human glioblastoma U87 and U118 
cell lines were obtained from the American Type 
Culture Collection (ATTC, Manassas, USA) and 
maintained in DMEM (Sigma-Aldrich Corporation, 
USA) supplemented with 10% foetal bovine serum 
(Sigma-Aldrich) and 1% penicillin and streptomycin 
(Sigma-Aldrich) at 37 C in a humidified atmosphere of 
5% CO2/95% air (NUAire DH Autoflow CO2 Air-
Jacked Incubator). 
Chicken embryos. The fertilised eggs (Gallus 
gallus) of meat breed Ross 308 (n = 60 for one glioma 
cell line) were supplied from a commercial hatchery. 
The eggs were incubated in the incubator ALMD-1N3-7 
with automatic egg rotation system (one full rotation per 
hour) at 37 C and 70% humidity. 
Culture of GMB cells on a chorioallantoic 
membrane. Eggs were divided into two groups of 60: 
U87 group and U118 group. After seven days of egg 
incubation, the silicone ring with the deposited  
3-4 × 106 U87 or U118 glioma cells suspended in  
30 μL of culture medium was placed on the chorio-
allantoic membrane (CAM) in the area of formed blood 
vessels. The eggs were incubated for 10 days, and then 
the tumours were resected for further analysis. Forty-
nine U87 and 24 U118 tumours were used. 
Cell morphology. U87 and U118 cells were 
plated on 6-well plates (1 x 10
5
 cells per well) and 
incubated for 24 h. The cells were stained with May-
Grünwald Giemsa method (Sigma-Aldrich). The 
morphology was recorded under an optical microscope 
(DM750; Leica Microsystems GmbH, Wetzlar, 
Germany) using LAS EZ version 2.0 software. 
Measurement and calculation of tumour 
volumes. The stereo microscope (SZX10, CellD 
software version 3.1; Olympus Corporation, Japan) was 
used to take digital photos of tumour. The 
measurements were taken with cellSens Dimension 
Desktop version 1.3 (Olympus). The tumour volumes 
were calculated with the following equation (9): 
 
 
where  
 
 
Histological and immunochemistry image 
analysis. After resection, tumours were fixed in 10% 
buffered formalin (Sigma-Aldrich). Samples were 
dehydrated and embedded in paraffin (Sigma-Aldrich). 
Sections of 5 μm were mounted on poly-L-lysine-
coated slides (Equimed, Poland) and stained with 
haematoxylin and eosin. For immunohistochemical 
analysis, proliferating cell nuclear antigen antibody 
(PCNA, DAKO M0879) in dilution 1:200 was used. 
PCNA-positive cells were visualized with Dako 
EnVision+System-HRP (Dako K 4010, Dako A/S, 
Denmark). 
Cells and tissues were measured using a Nikon 
ECLIPSE 90i microscope coupled with a digital 
camera Nikon DS5-U1 and NIS–Elements AR 
microscope imaging software (Nikon Corporation, 
Japan). Morphometric evaluation and image analysis 
were performed using 20 measurements of each sample 
at 400 × magnification. The total number of cells and 
PCNA positive cells were counted in visual fields  
(40 µm2) of the tissue. Mitotic index was assessed as 
the number of mitotic figures in 10 visual fields. 
TEM analysis. Tumour tissues were cut 
immediately after dissection into pieces of about  
1 mm
3
 and fixed in a 2.5% glutaraldehyde solution 
(Sigma-Aldrich) in 0.1 M phosphate buffer (pH 6.9). 
The samples were then rinsed in the same buffer, and 
transferred to a 1% osmium tetroxide solution (Sigma-
Aldrich) in 0.1 M phosphate buffer (pH 6.9) for 1 h. 
Subsequently, the samples were rinsed in distilled 
water, dehydrated in ethanol gradients, and impre-
gnated with epoxy embedding resin (Fluka Epoxy 
Embedding Medium Kit; Sigma-Aldrich). On the next 
day, the samples were embedded in the same resin and 
baked for 24 h at 36°C. The blocks were then 
transferred to a 60°C incubator and baked for another 
24 h. The blocks were cut into ultrathin sections  
(50–80 nm) using an ultramicrotome (Ultratome III; 
LKB Products, Sweden) and transferred onto copper 
grids, 200 mesh (Agar Scientific Ltd, United 
Kingdom). Subsequently, the sections were contrasted 
using uranyl acetate dihydrate (Sigma Aldrich) and 
lead citrate (lead (II) citrate tribasic trihydrate; Sigma-
Aldrich). The sections were examined under a JEM-
1220 transmission electron microscope (TEM) (JEOL, 
Japan). 
Statistical analysis. The data was analysed 
statistically by monofactorial analysis of variance, and 
the differences between groups were tested by multiple 
range Duncan test using Statistica version 10.0 
(StatSoft, USA). Differences with P < 0.05 were 
considered significant. 
Results 
Cell morphology. Both lines had different rates of 
growth and morphology (Fig. 1). U87 cells grew faster; 
they were bigger and had longer protrusions than U118 
cells. They continued to grow and formed multilayer 
spheroids at a high density, while U118 formed 
monolayers without spheroids and peeled off the plate, 
and died at a high density. 
Tumour morphology. The glioblastoma invaded 
CAM along its vessels (Fig. 2). In many cases tumours 
were observed outside the silicone ring. U87 and U118 
tumours had oval shape and visible blood vessels on 
the surface (Fig. 3). U87 tumours were bigger and had 
more visible vessels than U118 tumours (Table 1). 
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Fig. 1. Glioma cell lines: A, C - U87 glioma cell line; B - U118 glioma cell line. Arrows point to spheroids created by U87 cells 
 
 
 
Fig. 2. Glioblastoma multiforme grown on the chorioallantoic membrane. Scale bar: 200 µm 
 
 
 
 
Fig. 3. Isolated tumours. A, B - 87 tumour, C - 118 tumour. Scale bar: 200 µm 
 
 
Table 1. Characteristics of U87 and U118 glioma multiforme tumours 
Parameter 
Group ANOVA 
U87  
tumour 
U118  
tumour 
P-value 
SE – 
pooled 
Volume (mm3)  47.4 15.1 0.0011 6.76 
Average of number of glioma cells (on 40 µm2 area) 164 119 0.0000 5.6 
Average of number of PCNA positive cells (on 40 µm2 area) 
 
136 84 0.0025 6.1 
Mitotic index 9.29 4.33   
ANOVA - analysis of variance; SE – pooled standard error 
596 S. Jaworski  et al. / Bull Vet Inst Pulawy / 57 (2013) 593-598 
 
Histology and immunochemistry. In both 
tumours, the cell density was significantly higher than 
in the human brain nerve tissue (1). Size and shape of 
U87 and U118 cells revealed high polymorphisms. The 
picture of gliomas was characterised by the presence of 
different cells with small and larger atypical nucleous 
and high ratio of nucleus to cytoplasm (Fig. 4). The 
histological analysis revealed the presence of the 
multinucleated giant cells. In comparison to U87, the 
U118 tumour had a less compact structure and smaller 
amounts of cells in the tumour tissue (Table 1). Both 
tumours showed high mitotic activity; the mitotic index 
varied from 4.3 in U118 to 9.3 in U87 cells. 
Furthermore, PCNA staining showed a high 
proliferative activity of tumour: 74.6 % of U87 cells 
and 61.7% of U118 cells were PCNA positive (Fig. 5). 
Both cultured tumours showed a lot of features 
characteristic for human glioblastoma: nuclear atypia, 
mitotic cells, and cellular variety. 
TEM analysis of tumour. Fibroblast cells had 
elongated bodies, a rough endoplasmic reticulum 
(R.E.R), vacuoles, and groups of endocytotic vesicles. 
Most of the cells of both tumours had a high rate of 
protein synthesis what was confirmed by the highly 
developed R.E.R. The nuclei were elongated and had 
irregular shape, and unevenly distributed chromatin. A 
part of the nuclei contained spheroid bodies composed 
of granular material. Each cell line had mitochondria, 
which varied in size and shape, and were usually oval 
or elongated. U118 tumour cells were smaller in 
comparison to U87 cells, had a higher density of 
cytoplasm and a greater number of endocytotic vesicles 
(Fig. 6). 
 
 
 
Fig. 4. Histology of glioblastoma multiforme tumour cultured on chorioallantoic membrane: A, B, E, F - U87 tumour, C, D - U118 
 tumour. Black arrows point to blood vessels; white arrows show mitotic figures. Scale bar: 100 µm 
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Fig. 5. Immunoperoxidase staining of PCNA: A - U87 tumour, B - U118 tumour. Brown nuclei represent PCNA positive cells,  
blue – PCNA negative cells. Scale bar: 100 µm 
 
 
 
 
 
Fig. 6. Glioblastoma multiforme ultrastructure: A - U87, B - U118. 
CP – glioblastoma cell processes, EV – endocytotic vesicule, MF - 
myelin figures, Mi - mitochondrion, N - nucleus, RER - rough 
endoplasmic reticulum, SV - secretory vesicle, SB - spherical bodies. 
Scale bar: 2 μm 
Discussion 
The successful tumour therapy depends on a 
preclinical model, which can accurately reflect the 
growth and development of a tumour. Many studies are 
conducted with one-layer in vitro cultures, which have 
different morphology and physiology to a tumour. 
However, some cancer lines, i.e. glioma U87 cells, are 
able to create multi-layer spheroids (8). 
The chick CAM assay is a commonly used method 
for in vivo evaluation of tumour growth (6). In 
comparison to other animal models, based on cell 
implementation in rat brains or use of transgenic mice, 
the CAM model allows more accurate observation of 
tumour growth, especially when treating it with tested 
substances. A resection of the entire tumour is also 
possible (11, 13). This is more effective in developing 
tumours than a rodent model; compared to the rodent 
model, the CAM assay is much faster, allowing the 
observation of a tumour after a few days, while the 
rodent model requires much longer time, from one to 
four months (12). 
Two human glioblastoma cell lines: U87 and 
U118, using the CAM, were grown. In the case of 
tumour creation from U118, the results are restricted 
only to one study by Durupt et al. (7), where 
implementation of both cell lines was successful; 
however, the U87 cell line had a better ability to create 
noticeable tumours, as previously demonstrated by 
Balciūniene et al. (1). For the U118 line, the intensity 
of tumour creation was significantly lower; hence, only 
40% of inoculated eggs developed a tumour. Although 
both cell lines were visible  within 7 d of inoculation, 
the tumours were resected on the 10
th
 d when they were 
larger. The similar observation was noted by  
Grodzik et al. (9). In many cases, tumours were 
observed outside the silicone ring, as previously 
demonstrated by Szmidt et al. (14). All of the formed 
tumours possessed the ability to penetrate the 
membrane and were characterised by an invasive 
growth and strong angiogenic response. Culturing two 
types of glioblastoma tumours from U87 and U118 cell 
lines revealed a lot of differences in their morphology, 
histology, and ultrastructure; U87 tumours were larger 
and had more vessels. In this study, they were almost 
three times larger than U118 line tumours; however, 
compared to the results by Grodzik et al. (9), they were  
half the size of U87 tumours. U87 line cells sticked 
closely to each other and filled free spaces in a tumour, 
while U118 cells were loosely arranged. However, the 
100 µm 100µm 
A B 
A 
B 
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cell density in both cases was much higher than in the 
normal human brain nerve tissue (1). Furthermore, the 
histological analysis of tumours revealed the presence 
of multinucleated giant cells. Their characteristic 
features are large sizes with nuclei of variable number, 
size and shape (15). In this study, histological 
characteristics of GBM grown in ovo demonstrated 
several typical human-like features: high proliferation, 
cellular variety, nuclear atypia, and even mitotic cells, 
similarly to the results obtained by Hagedorn et al. 
(10). The present CAM model allows the growth of a 
GBM with features similar to human tumours. The 
model is simple and fast, and can be useful in the 
research of GBM, as well as other tumours.  
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